PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, and Department of Oral Immunobiology and Regenerative Medicine, Institute of Dentistry, Queen Mary University of London, UK.\', \'Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, and Department of Immunology, Royal London Hospital, Barts Health NHS Trust, London, UK.\', \'Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, UK. m.bombardieri@qmul.ac.uk.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.55563/clinexprheumatol/k7x3ta
?:hasPublicationType
?:journal
  • Clinical and experimental rheumatology
is ?:pmid of
?:pmid
?:pmid
  • 34919045
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 85
is ?:relation_isRelatedTo_publication of
?:title
  • Severity of COVID-19 infection in primary Sjögren\'s syndrome and the emerging evidence of COVID-19-induced xerostomia.
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34919045>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34919045>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all